NCT07193550 2026-02-27
A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)
M.D. Anderson Cancer Center
Phase 2 Recruiting
M.D. Anderson Cancer Center
Centre Leon Berard
Hackensack Meridian Health
Rutgers, The State University of New Jersey
Institut Claudius Regaud